US equities |
NVDA $241.56 ▲+1.11% SPCX $173.72 ▲+1.54% MU $1,064.99 ▲+0.10% AMD $655.94 ▲+3.83% MRVL $291.31 ▲+7.40% SNDK $1,667.28 ▼-2.16% AVGO $378.45 ▲+4.40% TSLA $380.98 ▲+0.59%
FinancialContent

Neuraxis, Inc. Common Stock (NY:NRXS)

7.104 -0.046 (-0.65%)
Delayed Quote Updated: 11:45 AM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Neuraxis, Inc. Common Stock

News headline image
iAccess Alpha Virtual Best Ideas Fall Investment Conference, September 15-16, 2026
From iAccess Alpha
Via ACCESS Newswire
With Only 1.21 Million In The Trading Float, NeurAxis Stock Volatility Exposes An Opportunity, Not A Deterrent ($NRXS)
Via AB Newswire
CEO Spotlight: NeurAxis CEO Explains His Better Way Of Treating Pediatric IBS And FAP ($NRXS)
Via AB Newswire
News headline image
NeurAxis Announces Positive University of Michigan IB-Stim™ Cost Effectiveness Study at ANMS 2023
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
Goldman Small Cap Research Publishes New Research Report on NeurAxis, Inc.
Via ACCESSWIRE
News headline image
NeurAxis Highlights Current Commercial Insurance Coverage with BCBS Massachusetts, BCBS South Carolina, BCBS Nebraska, and Quartz Wisconsin
From NeurAxis, Inc.
Via GlobeNewswire